Skip to main content Skip to main navigation menu Skip to site footer

Myelodysplastic Syndrome (MDS) in a Child who Transformed to Acute Myeloid Leukaemia with Myelodysplasia-Related Changes (AML-MRC)

  • Ni Komang Ayu Parmawati ,
  • Sianny Herawati ,
  • I Nyoman Wande ,


Background: Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell diseases, accounting for  < 5% of all hematologic malignancies in children.  MDS is characterized by cytopenia, dysplasia in one or more of the major myeloid lineages, ineffective hematopoiesis, and recurrent genetic abnormalities. Approximately 30% of patients with MDS show progression to AML within a few months up to several years. This is an MDS case report in children who have undergone Acute Myeloid Leukaemia transformation with Myelodysplasia-Related Changes (AML-MRC).

Case Report: A 16-year-old boy came to the Emergency Department of Sanglah General Hospital with a complaint of pain and swelling in both knees and joints since last month. Fatigue and fever happened a week before admission. Previously, he had been hospitalized twice with the same symptoms. Physical examination revealed pale conjunctiva with pancytopenia in the laboratory result. A blood smear showed normochromic normocytic anemia, neutropenia, and thrombocytopenia. Bone marrow aspiration morphology showed hypercellularity with blast presentation > 10% and multilineage dysplasia > 50% supporting MDS diagnosed transformation to Acute Myeloid Leukaemia with Myelodysplasia-Related Changes (AML-MRC). Leukemia phenotyping showed positive results on CD 33, CD 36 and HLA-DR presenting Monocytic Lineage.                                                                                                            

Conclusion: High degree dysplasia and blast percentage in blood and bone marrow increase tendency to transform into acute myeloid leukemia (AML). The diagnose of MDS requires analysis of blood and bone marrow morphology and cytogenetic analysis as a recommendation by WHO classification.


  1. World Health Organization. Classification of Tumours. In: Swerdlow SH, Campo E, Harris NL, Jaffe SE, Pileri SA et al. (eds.) Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th Ed. Genewa: International Agency for Research on Cancer. 2017: 98 – 152.
  2. Hofmann I, Elghetany TM. Myelodysplastic Syndromes and Myeloproliferative Disorders. In: Lanzkowsky P, Lipton J, Fish JD. (eds.) Lanzkowsky’s Manual Of Pediatric Hematology And Oncology. 6th Ed. New York: Elsevier. 2016: 348-355
  3. Bilal H, Naseem L, Siddiqui N. Myelodysplastic Syndrome in Childhood. Int J Pathol. 2015; 13(3):120–123.
  4. Wlodarski MW, Sahoo SS, Niemeyer CM. Monosomy 7 in Pediatric Myelodysplastic Syndromes. Hematol Oncol Clin North Am. 2018; 32(4):729–743.
  5. Hamed NAM. What is New in the 2016 Revision to WHO Classification of Myelodysplastic Syndromes? Canc Therapy & Oncol Int J. 2017; 4(4):555645.
  6. Germing U, Kobbe G, Haas R, Gattermann N. Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment. Dtsch Arztebl Int. 2013; 110(46):783–90.
  7. Hasle H. Myelodysplastic and myeloproliferative disorders of childhood. Hematology Am Soc Hematol Educ Program. 2016; 2016(1):598–604.
  8. Glaubach T, Robinson LJ, Corey SJ. Pediatric myelodysplastic syndromes: they do exist!. J Pediatr Hematol Oncol. 2014; 36(1):1–7.
  9. Rau ATK, Shreedhara AK, Kumar S. Myelodysplastic Syndromes in Children: Where Are We Today?. Ochsner J. 2012; 12(3):216–20.
  10. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20): 2391–405.
  11. Hofmann I. Pediatric myelodysplastic syndromes. J Hematopathol. 2015; 8(3):127–141.
  12. Kinoshita A, Miyachi H, Matsushita H, Yabe M, Taki T, Watanabe T et al. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/ Lymphoma Study Group. Br J Haematol. 2014; 167(1):80– 6.
  13. Xu XQ, Wang JM, Gao L, Qiu HY, Chen L, Jia L et al. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients. Am J Hematol. 2014; 89(9):874–81.

How to Cite

Parmawati, N. K. A., Herawati, S., & Wande, I. N. (2019). Myelodysplastic Syndrome (MDS) in a Child who Transformed to Acute Myeloid Leukaemia with Myelodysplasia-Related Changes (AML-MRC). Bali Medical Journal, 8(2), 450–454.




Search Panel

Ni Komang Ayu Parmawati
Google Scholar
BMJ Journal

Sianny Herawati
Google Scholar
BMJ Journal

I Nyoman Wande
Google Scholar
BMJ Journal